Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate
2010-02-24
2011-10-11
Stoica, Elly-Gerald (Department: 1647)
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
C435S325000
Reexamination Certificate
active
08034327
ABSTRACT:
The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects.
REFERENCES:
patent: 5153310 (1992-10-01), Mitchell et al.
patent: 5328988 (1994-07-01), Namen et al.
patent: 2005/0249701 (2005-11-01), Morre et al.
patent: 1391513 (2004-02-01), None
Axford, J.S. at al. “Glycobiology and Medicine”CPD Bulletin. Immunology and Allergy2004, pp. 85-88, vol. 3, No. 3.
Cebo, C. et al. “Lectin activities of cytokines: functions and putative carbohydrate-recognition domains”Biochemica et Biophysica Acta, Sep. 19, 2002, pp. 422-434, vol. 1572, No. 2-3.
Goodwin, R.G. at al. “Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells”PNAS, Jan. 1989, pp. 302-306, vol. 86.
Database Geneseq [Online], Nov. 4, 2004, XP002366778, Database Accession No. ADR05996, pp. 1-2.
University of Michigan Museum of Zoology web page: http://animaldiversity.ummz.umich.edu/site/accounts/information/Canidae.html; accessed Apr. 22, 2009.
Wells, J.A. “Additivity of Mutational Effects in Protein”Biochemistry, Sep. 18, 1990, pp. 8509-8517, vol. 29, No. 37.
Skolnick, J. et al. “From genes to protein structure and function: novel applications of computational approaches in the genomic era”Trends in Bioctech., 2000, pp. 34-39, vol. 18, No. 1.
Ju, G. et al. “Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis”Proc. Natl. Acad. Sci. USA, 1991, pp. 2658-2662, vol. 88.
Whisstock, J.C. at al. “Prediction of protein function from protein sequence and structure”Quarterly Rev. Biophys., 2003, pp. 307-340, vol. 36.
Whistow, G.J. et al. “Tau-Crystallin/alpha-Enolase: One Gene Encodes Both an Enzyme and a Lens Structural Protein”J. Cell Biol., 1988, pp. 2729-2736, vol. 107.
Assouline Brigitte
Breque Corinne
Gregoire Anne
Morre Michel
Rance Iann
Cytheris
Saliwanchik Lloyd & Eisenschenk
Stoica Elly-Gerald
LandOfFree
Hyperglycosylated IL-7, preparation and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hyperglycosylated IL-7, preparation and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hyperglycosylated IL-7, preparation and uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4293884